In vitro inhibition of the replication of human immunodeficiency virus type 1 by β-mercaptoethylamine (cysteamine)

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 214-218

  Bergamini, Alberto ^a   Ventura, Laura ^b   Mancino, Giorgio ^b   Capozzi, Marcella ^b   Placido, Roberta ^b   Salanitro, Agata ^b   Cappannoli, Luisa ^b   Faggioli, Emanuela ^b   Stoler, Andrea ^b   Rocchi, Giovanni ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; MERCAPTAMINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CYSTINOSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 19244361807     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.214     Document Type: Article

References (15)

1. Markello TC, Bernardini ME, Gahl WA. Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 1993;328:1157-62.
2. Bergamini A, Capozzi M, Ghibelli L, et al. Cystamine potently suppresses in vitro HIV-1 replication in acutely and chronically infected human cells. J Clin Invest 1994;93:2251-7.
3. Ho WZ, Zhu XU, Song L, Cutilli JR, Douglas SD. Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages. AIDS Res Hum Retroviruses 1995;11:451-9.
4. Perno CF, Yarchoan R, Cooney DA, et al. Inhibition of human immunodeficiency virus (HIV-1/HTLV-III-Ba-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2′,3′-dideoxynucleosides. J Exp Med 1988;168:1111-25.
5. Karber G. Beitrag zur kollektiven Behandlung Pharmakologischer Reihenversuche. Arch Exp Pharmakol 1931;162:480-3.
6. Pauwels R, BalzariniJ, Baba M, et al. Rapid and automated tetrazolium based colorimetric assay for the detection of anti - HIV-1 compounds. J Virol Methods 1988;20:309-21.
7. Bergamini A, Perno CF, Capozzi M, et al. A tetrazolium-based colorimetric assay for quantification of HIV-1 - induced cytopathogenicity in monocyte-macrophages exposed to macrophage-colony stimulating factor. J Virol Methods 1992;40:275-86.
8. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1982.
9. Di Marzo Veronese F, De Vico AL, Rahman R, Oroszlan S, Gallo RC, Sarngadharan MG. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 1986;231:1289-95.
10. Roederer M, Staal FJT, Raju PA, Ela SW, Herzenberg LA, Herzenberg LA. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci USA 1990;87:4884-8.
11. Pani A, Marongiu ME, La Colla P. Modulatory effect of N-acetyl-L-cysteine on the HIV-1 multiplication in chronically and acutely infected cell lines. Antiviral Res 1993;22:31-4.
12. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
13. Weisgraber KH, Innerariry TL, Mahly RW. Abnormal lipoprotein receptor binding activity of human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 1981;257:2518-21.
14. Corden BJ, Schulman JD, Schneider JA, Thoene JG. Adverse reactions to oral cysteamine use in nephropathic cystinosis. Dev Pharmacol Ther 1981;3:25-30.
15. Smolin LA, Clark KF, Thoene JG, Gahl WA, Schneider JA. A comparison of the effectiveness of cysteamine and phosphocysteamine in elevating plasma cysteamine concentration and decreasing leukocyte free cystine in nephropathic cystinosis. Pediatr Res 1988;23:616-20.